Jeffrey Ryan Stewart net worth and biography

Jeffrey Stewart Biography and Net Worth

EVP of AbbVie
Jeffrey R. Stewart is Executive Vice President, Chief Commercial Officer. He is responsible for leading the largest commercial area for the enterprise encompassing multiple therapeutic areas across immunology, oncology, virology, eye care, neuroscience, endo-metabolics, gastroenterology, specialty products and women’s health.

Mr. Stewart joined Abbott in 1992 as part of TAP, Abbott’s former U.S. joint venture with Takeda Chemical Industries. Following his time with TAP, Mr. Stewart held various leadership positions in Abbott’s U.S. and international pharmaceutical businesses, including Divisional Vice President, Immunology; Divisional Vice President, Primary Care; General Manager, Virology; and General Manager, United Kingdom. Prior to AbbVie's separation from Abbott in January 2013, Mr. Stewart served as Vice President, Abbott Proprietary Pharmaceutical Division, United States.

Mr. Stewart previously led the U.S. Area for 10 years, including most recently as Senior Vice President, U.S. Commercial Operations.
Mr. Stewart previously served on the Board of the National Pharmaceutical Council and serves on the Board of the Pharmaceutical Research and Manufacturers of America (PhRMA). At AbbVie, he is the executive chair of the PRIDE Employee Resource Group.

What is Jeffrey Ryan Stewart's net worth?

The estimated net worth of Jeffrey Ryan Stewart is at least $9.46 million as of March 13th, 2023. Mr. Stewart owns 60,941 shares of AbbVie stock worth more than $9,464,137 as of March 24th. This net worth approximation does not reflect any other assets that Mr. Stewart may own. Learn More about Jeffrey Ryan Stewart's net worth.

How do I contact Jeffrey Ryan Stewart?

The corporate mailing address for Mr. Stewart and other AbbVie executives is 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL, 60064. AbbVie can also be reached via phone at (847) 932-7900. Learn More on Jeffrey Ryan Stewart's contact information.

Has Jeffrey Ryan Stewart been buying or selling shares of AbbVie?

During the last quarter, Jeffrey Ryan Stewart has sold $8,089,875.00 of AbbVie stock. Most recently, Jeffrey Ryan Stewart sold 53,125 shares of the business's stock in a transaction on Monday, March 13th. The shares were sold at an average price of $152.28, for a transaction totalling $8,089,875.00. Following the completion of the sale, the executive vice president now directly owns 60,941 shares of the company's stock, valued at $9,280,095.48. Learn More on Jeffrey Ryan Stewart's trading history.

Who are AbbVie's active insiders?

AbbVie's insider roster includes Carlos Alban (Vice Chairman), Roxanne Austin (Director), Nicholas Donoghoe (SVP), Brian Durkin (VP), Richard Gonzalez (CEO), Henry Gosebruch (EVP), Robert Michael (Vice Chairman), Scott Reents (Sr. VP & CFO ), Timothy Richmond (EVP), Azita Saleki-Gerhardt (EVP), Laura Schumacher (Vice Chairman), Michael Severino (Vice Chairman), Elaine Sorg (SVP), Jeffrey Stewart (EVP), and Carrie Strom (SVP). Learn More on AbbVie's active insiders.

Are insiders buying or selling shares of AbbVie?

During the last year, insiders at the sold shares 14 times. They sold a total of 693,567 shares worth more than $106,210,421.50. The most recent insider tranaction occured on March, 13th when EVP Jeffrey Ryan Stewart sold 53,125 shares worth more than $8,089,875.00. Insiders at AbbVie own 0.1% of the company. Learn More about insider trades at AbbVie.

Information on this page was last updated on 3/13/2023.

Jeffrey Ryan Stewart Insider Trading History at AbbVie

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/13/2023Sell53,125$152.28$8,089,875.0060,941View SEC Filing Icon  
3/24/2022Sell27,690$159.20$4,408,248.00View SEC Filing Icon  
12/15/2021Sell2,152$128.00$275,456.00View SEC Filing Icon  
12/29/2020Sell25,290$105.00$2,655,450.0076,259View SEC Filing Icon  
5/12/2020Sell23,024$90.00$2,072,160.0052,760View SEC Filing Icon  
8/16/2019Buy15,552$64.44$1,002,170.8865,304View SEC Filing Icon  
See Full Table

Jeffrey Ryan Stewart Buying and Selling Activity at AbbVie

This chart shows Jeffrey Ryan Stewart's buying and selling at AbbVie by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AbbVie Company Overview

AbbVie logo
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Read More

Today's Range

Now: $155.30
Low: $154.02
High: $156.50

50 Day Range

MA: $150.96
Low: $144.61
High: $156.77

2 Week Range

Now: $155.30
Low: $134.09
High: $175.91


4,583,741 shs

Average Volume

7,621,192 shs

Market Capitalization

$273.97 billion

P/E Ratio


Dividend Yield